Cooperation between Bausch & Lomb and Phase Forward
The worldwide reputable eye care company Bausch & Lomb built new partnership with Phase Forward, which focuses on data management solutions for clinical trials and drug safety. As two leading companies in their respective fields, Bausch & Lomb and Phase Forward signed a multi-year contract.
Both of the two sides were satisfied with this new relationship. For Bausch & Lomb, clinical trials of eye health products are a critical element. The firm aims to develop the highest quality eye health products in the most efficient manner. According to Bausch & Lomb’s vice president and chief technology officer John W. Sheets, the company could get an effective solution for automating and optimizing trial management from Phase Forward.
According to chairman and CEO of Phase Forward named Bob Weiler, it was an honor for Phase Forward to cooperate with Bausch & Lomb. In other words, Phase Forward was quite willing to provide good services to all of its customers, including this new one.
In detail, Bausch & Lomb will implement Phase Forward’s InForm Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding module. All units of Bausch & Lomb will be covered by this solution, including Surgical, Vision Care and Pharmaceuticals products.
As a full integrated module of InForm, the Central Coding module to be implemented by Bausch & Lomb is multi-functional. While ensuring coding consistency and accuracy, the Central Coding module can streamline the process of coding medical terms and automating manual tasks. Bausch & Lomb will apply InForm GTM from Phase Forward earlier in its development circle, in order to view and act on clinical trial data.